Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer-Reference-Cited by-全球学者库

Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Published:2018-01-11 Issue:2 Volume:378 Page:113-125
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Soria Jean-Charles¹,Ohe Yuichiro¹,Vansteenkiste Johan¹,Reungwetwattana Thanyanan¹,Chewaskulyong Busyamas¹,Lee Ki Hyeong¹,Dechaphunkul Arunee¹,Imamura Fumio¹,Nogami Naoyuki¹,Kurata Takayasu¹,Okamoto Isamu¹,Zhou Caicun¹,Cho Byoung Chul¹,Cheng Ying¹,Cho Eun Kyung¹,Voon Pei Jye¹,Planchard David¹,Su Wu-Chou¹,Gray Jhanelle E.¹,Lee Siow-Ming¹,Hodge Rachel¹,Marotti Marcelo¹,Rukazenkov Yuri¹,Ramalingam Suresh S.¹

Affiliation:

1. From Gustave Roussy Cancer Campus and University Paris-Sud, Orsay, France (J.-C.S., D.P.); the Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo (Y.O.), the Department of Thoracic Oncology, Osaka International Cancer Institute (F.I.), and the Department of Thoracic Oncology, Kansai Medical University Hospital (T.K.), Osaka, the Department of Thoracic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama (N.N.), and the Research Institute for Diseases of the Chest...

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1713137

Cited by 3382 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib-induced Keratitis and Secondary Toxic Epidermal Necrotic Drug Eruption- A Case Report and Literature Review;Current Drug Safety;2024-05

2. Treatment of non-small cell lung cancer with Yiqi Buxue prescriptions combined with adjuvant chemotherapy on the cancer therapy-related cardiovascular toxicity: A systematic review and meta-analysis;Journal of Ethnopharmacology;2024-04

3. EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment: A multicenter retrospective observational study;Respiratory Investigation;2024-03

4. miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44;Molecular Therapy - Nucleic Acids;2024-03

5. Comprehensive analysis reveals the prognostic and immunogenic characteristics of DNA methylation regulators in lung adenocarcinoma;Respiratory Research;2024-02-05